Related Experiment Video
Updated: May 6, 2026
04:34
Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
Published on: June 15, 2011
18.0K
Statins, fibrates, and venous thromboembolism: a meta-analysis
Alessandro Squizzato1, Matteo Galli, Erica Romualdi
1Department of Clinical Medicine, University of Insubria, Varese, Italy. alexsquizzo@libero.it
European Heart Journal
|December 25, 2009
Summary
This review found that statins may reduce the risk of venous thromboembolism (VTE), while fibrates may increase VTE risk. Further research is needed to confirm these findings on lipid-lowering drugs and VTE.
Area of Science:
- Cardiovascular medicine
- Pharmacology
- Epidemiology
Background:
- Lipid-lowering drugs are widely used to manage dyslipidemia.
- Venous thromboembolism (VTE) is a significant health concern with multifactorial causes.
- The relationship between lipid-lowering therapies and VTE risk requires clarification.
Purpose of the Study:
- To systematically review and meta-analyze the existing literature on the association between lipid-lowering drugs and the occurrence of VTE.
- To specifically assess the impact of statins and fibrates on VTE risk.
Main Methods:
- A comprehensive literature search was conducted in MEDLINE and EMBASE databases up to April 2009.
- Included studies were categorized by quality, and data were pooled using fixed and random-effects models.
- Meta-analysis included three RCTs, three cohort studies, and eight case-control studies, totaling 863,805 patients.
Main Results:
- Statin use was associated with a significant reduction in VTE risk (OR, 0.81; 95% CI, 0.66-0.99) with high heterogeneity.
- Fibrate use showed a significant increase in VTE risk (OR, 1.58; 95% CI, 1.23-2.02) without heterogeneity.
- Data on other lipid-lowering agents were insufficient.
Conclusions:
- Statins may potentially lower the risk of VTE, while fibrates may increase it.
- Methodological limitations necessitate cautious interpretation of these findings.
- Further well-designed randomized controlled trials are recommended to validate these associations.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
01:26Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
01:30Venous Thrombosis I: Introduction
834
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
834
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
470
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
470
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
01:30Venous Thrombosis IV: Nursing Management
418
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
418